| Literature DB >> 35615605 |
Abstract
Although no scoring system is as yet fully validated for predicting maternal outcomes in critically ill obstetric patients, prognostication may be done objectively using severity predicting models. General critical care scoring systems which have been studied in obstetric patients are outcome prediction models (Acute Physiology and Chronic Health Evaluation [APACHE] I-IV, Simplified Acute Physiology Score [SAPS] I-III, Mortality Probability Model [MPM] I-IV) and organ dysfunction scores (Multiple Organ Dysfunction Score [MODS], Logistic Organ Dysfunction Score [LODS], Sequential Organ Failure Assessment [SOFA]). General critical care scoring systems may overpredict mortality rates in obstetric patients secondary to an altered physiology of organ systems during pregnancy. Obstetric prediction models were developed keeping in mind the physiological characteristics of obstetric population. They are Modified Early Obstetric Warning System (MEOWS), Obstetric Early Warning Score (OEWS), Maternal Early Warning Trigger (MEWT), and disease-specific obstetric scoring systems. The APACHE II model and MPM II are most often used scoring systems for predicting maternal mortality. The SOFA model is the best predictive model for sepsis in obstetrics. APACHE II and SAPS are more useful for nonobstetric population. Recent studies have also underscored the applicability of the OEWS in intensive care unit (ICU) settings with results comparable to the more elaborate APACHE II and SOFA scores. The Early Warning System helps in identifying acutely deteriorating pregnant and postpartum women in non-ICU settings who may require critical care. Fetal outcomes are largely dependent upon maternal outcomes. Prognostic systems applied to mothers may help in estimation of perinatal mortality and morbidity. How to cite this article: Suri J, Khanam Z. Prognosticating Fetomaternal ICU Outcomes. Indian J Crit Care Med 2021;25(Suppl 3):S206-S222.Entities:
Keywords: Delays; Fetomaternal outcome; ICU; Mortality; Mortality prediction; Obstetric critical care; Predictive model; Pregnancy
Year: 2021 PMID: 35615605 PMCID: PMC9108782 DOI: 10.5005/jp-journals-10071-24022
Source DB: PubMed Journal: Indian J Crit Care Med ISSN: 0972-5229
Studies on maternal outcomes and their predictors in obstetric patients admitted in the ICU
|
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lapinsky et al.[ | 332 | Retrospective review | — | PIH and its complications (42%) Obstetric hemorrhage (17%) Obstetric sepsis (16%) Others (23%) | — | — | [ | 12 | 0.43 (0.52 on adding diagnostic weightage) for APACHE-II; 0.89 for SAPS-II | — | OR for maternal mortality (95% CI) ( |
| Lin et al.[ | 207 | Retrospective analysis | 42/10,000 deliveries | Direct obstetric cause (most common)—massive postpartum hemorrhage (20.29%), PIH (17.39%), acute fatty liver (13.04%), DIC (11.11%) Nonobstetric cause—Heart failure (most common cause) | — | >3 D (52.66%) | — | 1.93 | — | AFLP, DIC | OR for prolonged ICU stay PaO2/FiO2: 4.73 (1.46–11.37) ( |
| Gupta et al.[ | 24 | Prospective analysis | 0.14% ICU utilization ratio | Obstetric cause most common (91.66%)—obstetric hemorrhage ( | I: 91.66% MV: 70.83% | 39.42 ± 33.7 hr | ROC-AUC for MPM II scores: 0.74 Predicted maternal mortality by MPM II: 26.43% ( | 41.67 | 1.57 | Sepsis, MODS, DIC | ICU-LOS— Shorter in nonsurvivors. |
| Rios et al.[ | 242 | Retrospective cohort study | 8.1/1,000 deliveries | Obstetric cause (most common)—PIH, PPH, sepsis Nonobstetric— severe community acquired pneumonia (most common) | MV: 13.6% | 2 (2–4) D | APACHE II—score: 6 (4–8) (higher scores in nonobstetric cause of admission, | 2.5 | — | Pulmonary embolism, multiorgan failure, pneumonia, HELLP syndrome | Mortality higher among the patients admitted for nonobstetric reasons. APACHE scores >8 associated with prolonged hospital stay (OR, 1.7; 95% CI, 1.3–8.7) |
| Devabhaktuni et al.[ | 52 | Prospective observational study | — | Obstetric/ direct indication: PIH (30.76%); obstetric hemorrhage (23.07%) Indirect causes: 11% Nonobstetric indication: 13% | I: 38.46% MV: 51.92% T: 50% D: 19.3% | 4.2 ± 2.38 D | Disease severity scores (survivor vs dead, | 6.25 | — | DIC, massive intracranial hemorrhage, hypoxic is- chemic encephalopathy | Significant predictor of maternal outcome: Use of MV ( |
| Saif et al.[ | 224 | Prospective cohort study | 1.17% of all deliveries. 72.9% of total ICU admissions | Overall most common indication: obstetric hemorrhage (22.8%) Most common indication in Antepartum period-PIH (19.5%); In postpartum period- Obstetric hemorrhage (35%) | — | 2.3 ± 0.9 D | APACHE II score: 20.17 ± 9.60; AUROC 0.811 (0.752–0.871); Predicted maternal mortality by APACHE II: 38.3 SAPS II score: 36.14 ± 14.89; AUROC 0.863 (0.808–0.971); Predicted maternal mortality: 27.6 | 35.3 | APACHE II: 0.92 SAPS II: 1.27 | Congestive cardiac failure, sepsis, hepatic encephalopathy, obstetric hemorrhage, pulmonary edema, and perforation peritonitis | OR for maternal mortality—Lack of antenatal care: 81.6 (23.8–279.7), |
| Vasquez et al.[ | 376 | Multicenter, prospective, national cohort study | 0.9/1,000 deliveries | Nonobstetric indications (54%) most common. Obstetric indications (46%): PIH with HELLP syndrome, obstetric hemorrhage, sepsis. | MV: | 2 (2–4) D | APACHE II score: 8 (4–12) (higher scores in nonobstetric cause of admission, | 3.6 | Using APACHE II: Overall—0.47; Obstetric cause of admission —0.3; Non- obstetric cause of admission —1.25 | MODS, shock, renal dysfunction, ARDS | OR for MFN mortality—MODS: 2.28 (1.03–5.04); Years of education: 0.89 (0.80–0.98), |
| Seppänen et al.[ | 291 | Retrospective audit design | — | Obstetric indications (90.7%): PIH (57%), obstetric hemorrhage (25.4%) | MV: 18.2% (MV requirement more in operated women) T: 26.5% | Median: 21.0 (16.0—27.0) H | Severity of illness scores— APACHE II: 9.0 (IQR: 7–12). SAPS II: 14 (10–20.3). SOFA: 2 (1–4). | 0.3 | — | Prolonged stay in ICU (1%), septic shock (0.7%), DIC (1%) | Higher disease severity scores (APACHE II, SAPS II, SOFA, and intervention scores) (TISS-76) scores for vaginal delivery and for patients admitted for nonobstetric reasons |
| Nonobstetric indications (9.3%): heart disease, respiratory failure, infection | Intensity of treatment score— TISS-76: Daily median of 21.5 (18.0—25.5). | ||||||||||
| Aarvold et al.[ | Septic women: 146 pregnant, 298 non- pregnant | Cohort study | — | Most common cause of sepsis in obstetric patients: Puerperal sepsis | — | — | AUROC for predicting maternal mortality: SOS: 0.67 APACHE II: 0.68 SOFA: 0.79 MODS: 0.84 SAPS II: 0.72 | 81 (pregnant) | — | — | SOS was not better than APACHE II, SAPS II, SOFA and MODS for predicting maternal mortality. MODS score best mortality predictor of obstetric women with sepsis. |
| Joseph et al.[ | 109 | Retrospective cum prospective observational study | — | PIH with HELLP (38.5%) Anemia (19.27%) Antepartum hemorrhage | Invasive ventilation: 73.39% | Mean 3.47 ± 3.16 D | APACHE 11 score: Mean 16.89 ± 7.48 | 17.76 | — | — | Higher APACHE II scores (>30) associated with 62.5% maternal deaths. |
| Oliveira-Neto et al.[ | 279 | Retrospective cohort study | 34.6/1,000 livebirths | Direct obstetric ( | — | 1–2 D (70.9%) | Mean scores for SMO vs non-SMO and AUROC (95% CI) for SMO—APACHE II: 11.77 (±6.43) vs 6.39 (±3.21), | 7.7 | APACHE II: 0.73 (0.56–0.93) APACHE IV: 0.55 (0.42–0.70) SAPS III: 0.74 (0.57–0.94) SOFA24: 0.96 (0.74–1.22) | — | Longer ICU-LOS associated with SMO (OR (95% CI) 3.60 (2.08–6.43), |
| (±9.95), | APACHE IV and SAPS III not recommended for SMO prediction. Total SOFA and APACHE II best for predicting SMO, with total SOFA as the recommended predicting model in obstetric population and APACHE II in cases of obstetric hemorrhage. | ||||||||||
| Prin et al.[ | 105 | Prospective observational cohort study | 23% of all ICU admissions | Shock (40%), respiratory failure (22%), PIH (11%) | I: 48% MV: 95% T: 63% | 2D (IQR 1–5) | 41 | — | OR for mortality— Increasing age: unadjusted OR 0.94 (0.89–0.99), | ||
| Lawton et al.[ | 400 | National retrospective cohort study | 7/1000 births | Blood loss/obstetric hemorrhage (31.9%) PIH (30.4%) Sepsis (14.2%) | — | — | — | — | High risk of maternal morbidity— Pacific islander ethnicity, <20 or >40 Y age, multiple pregnancy, preterm delivery. | ||
| Maiden et al.[ | 183 | Registry-based cohort study | 1.3% of ICU admissions | Obstetric indication (65%)— pregnancy- related postop disorder (46%), PPH (11%), PIH (9%) Nonobstetric indication (35%)— respiratory disorder, cardiac disorder, sepsis | MV: 19% | 1.1 (0.7–1.8) D | APACHE-III-J score: Median 32 (IQR 23–42) Risk of death (%) by APACHE-III-J: Mean 4.7 ± 9.4 Risk of death (%) by ANZROD: Mean 1.3 ± 5.6 | 0.57 | — | — | 90% deaths in nonobstetric indications for admission. Higher mortality and prolonged ICU-LOS seen in MV and referred patients. ANZROD is a better predictor of mortality than APACHE-III-J. |
| Miglani et al.[ | 124 | Prospective cross-sectional observational study | 0.77% of total obstetric admissions | Obstetric hemorrhage (37.1%), PIH (25.8%) | I: 47.58% MV: 66.12% T: 83.87% S: 25% | 3.18 ± 2.40 D | APACHE II score: Mean 14.77 ± 6.85 Predicted mortality rate by APACHE II—25% | 30.6 | 1.224 | — | High APACHE II score with ICU-LOS (p =0.001), maternal mortality ( |
| Khergade et al.[ | 250 | Prospective cohort | Obstetric hemorrhage (20%)’ sepsis (18.8%), PIH (15.6%), anemia (17.6%) | Mean scores; AUROC (95%CI): OEWS 8.2 ± 5.22; 0.894 (95% CI, 0.849–0.929), | 26 | OEWS 0.663 SOFA 0.625 APACHE II 0.691 | — | OEWS is as effective as the conventional SOFA and APACHE II to prognosticate the obstetric patient. Higher OEWS scores in prolonged ICU-LOS (0.0297) and hours of MV (0.0255). Advantage of OEWS is that it does not need any laboratory parameter and hence, calculation is easy and less time-consuming | |||
| Jain et al.[ | 90 | Descriptive observational study | 0.4% of total obstetric admissions; 9% of total ICU admissions | Obstetric indications-PIH (37.7%), obstetric hemorrhage (28.8%) Nonobstetric indications—cardiac disease, epilepsy, severe anemia | I: 31.1% MV: 94.4% B <5 units: 84.4% | 33.3% mortality; 16.7% recovered with morbidity; 50% recovered | — | Mortality to morbidity ratio—Obstetric hemorrhage 1:2.8; PIH 1:6.2 Higher mortality associated with inotropic support Lower mortality associated with early surgical interventions Increased risk of admission with referred patients, low socioeconomic status, level 1, 2, 3 delay and increased delay duration to admission. | |||
*Values are mean (SD) or median (IQR-interquartile range);
Severity of illness scores were not significantly altered by modification for obstetrical normal values (APACHE-OB or SAPS-OB);
level 1, 2, 3 delays—delay in seeking care, in reaching appropriate healthcare facility, and at tertiary care centre, respectively;
****Group 1 requiring level 1 and 2 support, Group 2 requiring level 3 support; D, Days; W, Weeks; Y, Years; GA, gestational age; P, Parity; MV, mechanical ventilation; I, Inotropic support; t, Blood Transfusions; S, Surgical interventions; D, Dialysis; N, Number of women; PIH, Pregnancy-induced Hypertension; PPH, Postpartum hemorrhage; ICU LOS, ICU-Length of stay; SAPS, Simplified Acute Physiology Score; APACHE, Acute Physiology and Chronic Health Evaluation; MPM, mortality probability models; SMR, Standardized Mortality Rate i.e., number of observed deaths/number of expected deaths (values <1 means predictor overestimates mortality, >1 underestimates mortality); PMR, Prediction of mortality rates; AUROC, Area under Receiver Operating Curve; CS, cesarean section; MFN, Materno-fetal-neonatal; SMO, Severe Maternal Outcomes (near miss + maternal deaths); OR, Odds ratio; CI, Confidence interval; DBP, Diastolic Blood Pressure; SBP, Systolic Blood Pressure; ANZROD, Australian and New Zealand Risk of Death Model (includes obstetric patients); MCCWG LOC, maternal critical careworking group level of support for critical care; OEWS, Obstetric early warning score; SOS, Sepsis obstetric score. Color coding—Green for studies conducted in developing nations, blue for studiesconducted in developed nations, pink for studies in least developed countries, yellow for multicountry studies with developed/developing economies
Critical care severity scoring system
|
| ||
|---|---|---|
|
|
|
|
| Maternal Critical Care | Level 0: Normal ward case | |
| Acute Physiological and Chronic Health Evaluation II (within 24 hr of ICU admission) |
Acute physiological score (12 variables taken during first 24 hr of admission): rectal temperature; MAP; HR; RR; oxygen; arterial pH; serum HCO3; serum sodium; serum potassium; serum creatinine; hematocrit; white blood cell count; GCS Age points Chronic health points | APACHE II score = A + B + C (range 0–71) |
| APACHE III | Two parts:
APACHE III score—similar to APACHE II, except GCS not used and two new variables added (patient's origin and lead- time bias) APACHE III predictive equation—to provide risk estimates of hospital mortality | APACHE III score range 0–299 |
| APACHE IV | Same variables as APACHE III plus new variables (mechanical ventilation, thrombolysis, impact of sedation on GCS, rescaled GCS, PaO2/FiO2 ratio). | |
| Simplified Acute Physiological Score II (within 24 hr of ICU admission) |
Physiological score (12 variables): heart rate; SBP; temperature; PaO2/FiO2; urine output; urea; TLC; potassium; sodium; bicarbonate; bilirubin; GCS Age score Chronic disease score: metastatic cancer; hematological malignancy; AIDS Type of admission score: scheduled surgical; medical; emergency surgical | SAPS II score range 0–163. Probability of death calculated using SAPS II score using logistic regression. |
| SAPS III (within 1 hr of ICU admission) | Age; LOS before ICUA; intrahospital location (OR, ER, other ICU, other); comorbidities (cancer therapy, cancer, hematologic cancer, AIDS, chronic HF (NYHA IV), cirrhosis); vasoactive drugs before ICUA; ICU admission (planned, unplanned); reason for admission (cardiovascular, hepatic, digestive, neurologic); surgical status at ICUA (scheduled surgery, emergency surgery, no surgery); site of surgery (transplant, trauma, cardiac surgery, neurosurgery); acute infection at ICUA (nosocomial, respiratory); GCS; highest total bilirubin; highest body temperature; highest creatinine; highest HR; lowest WBC count; lowest pH; lowest platelet; lowest SBP; MiV or CPAP PaO2/FiO2 | |
| Mortality Prediction |
MPM 0—medical/unscheduled surgery admission; metastatic neoplasm; cirrhosis; chronic renal insufficiency; CPR prior to admission; coma (GCS 3–5); HR; SBP; acute renal insufficiency; cardiac arrhythmia; cerebrovascular incident; GI bleeding; intracranial mass; mechanical ventilation; age MPM—24, 48, 72 hr: medical or unscheduled admission; metastatic neoplasm; cirrhosis; creatinine >177 µmol/L; urine output <50 mL/8 hr; coma; confirmed infection; intracranial mass; vasoactive drugs ≥1 hr; PaO2 <60 Torr; PT >standard + 3 sec; age | Calculates predicted death rate using logistic equation. |
| Multiple Organ Dysfunction Score | 6 organ systems and their variables: hematological (platelet count); hepatic (serum bilirubin); renal (serum creatinine); cardiovascular (PAR); GCS; respiratory (PO2/FiO2) | MODS score range 0–24 |
| Sequential Organ Failure Assessment Score | 6 organ systems: pulmonary (lowest PaO2/FiO2 %); coagulation (lowest platelet count); hepatic (highest bilirubin); circulatory (blood pressure status); neurological (GCS); renal (highest creatinine levels and total urine output) | SOFA score range 0–6. |
| Logistic Organ Dysfunction Score | 6 organ systems: neurological (GCS); cardiovascular (HR and SBP); renal (urea nitrogen, serum creatinine and urine output); respiratory (PaO2/FiO2 %); hematological (TLC and platelet count); hepatic (serum bilirubin and PT) | Calculates probability of death using an equation. |
| Quick SOFA for sepsis | Altered mental status (GCS <15); respiratory rate ≥22; systolic BP ≤100 | |
| Organ dysfunction and/or infection | 7 variables: respiratory; cardiovascular; renal; neurological; hepatic; hematological; infection (with clinical evidence) | |
| Three days recalibrated ICU outcome score | Transfer from ward; chronic illness; SAPS II Day 2—SAPS II Day 3 alteration; LODS Day 2—LODS Day 3 alteration; LODS on admission; SAPS II on admission | Scores help in calculating mortality based on regression model |
| Obstetric prediction models | ||
| Obstetric Early Warning Score | SBP; DBP; RR; HR; oxygen required to maintain SpO2 96%; temperature; consciousness level | |
| Modified Obstetric Early Warning Score | 8 variables: temperature; SBP; DBP; HR; RR; level of consciousness on the AVPU scale; urine output Each variable classified into yellow or red alert according to findings. | |
| Maternal Early Warning Criteria | SBP <90 or >160; DBP >100 m; HR <50 or >120; RR <10 or >30; oxygen saturation on room air <95%; oliguria <35mL/hr ≥ 2 hr Each variable classified into yellow or red alert according to findings | |
| Maternal Early Warning System | SBP <80 or >160; DBP >105; HR <50 or >120; RR <10 or >30; oxygen saturation <95% on room air at sea level; oliguria <30 mL for 2 hr; maternal agitation/confusion/unresponsiveness; preeclampsia with nonremitting headache or shortness of breath | |
| New Early Warning Score | RR; O2 saturation; supplemental oxygen; temperature; SBP; HR; APUV level of consciousness | |
| Maternal Early Warning | SBP; DBP; HR; RR; temperature; oxygen saturation; altered mental status. | |
| Trigger | Each variable classified into yellow or red alert according to findings | |
| Obstetric modified qSOFA | SBP ≤ 90 mm Hg; RR >25/min and altered mentation. | |
| Sepsis Obstetric Score | Temperature; SBP; HR; RR; O2 saturation; WBC counts; serum lactic acid | |
| miniPIERS (Preeclampsia Integrated Estimate of Risk) model: risk prediction model for PIH | Parity (nulliparous vs multiparous); gestational age on admission; headache/visual disturbances; chest pain/dyspnea; vaginal bleeding with abdominal pain; systolic blood pressure; and dipstick proteinuria. | |
| fullPIERS model: risk prediction model for PIH. Gives probability of adverse maternal outcomes with PIH. | Gestational age; chest pain or dyspnea; SpO2; platelet count; creatinine; AST/ALT | |
GCS, Glasgow Coma Score; HR, heart rate (beats per min); RR, respiratory rate (breaths per min); SBP, systolic blood pressure (mm Hg); DBP, diastolic blood pressure (mm Hg); MAP, mean arterial pressure (breaths per min); PaO2 (mm Hg), arterial oxygen tension; FiO2, fractional concentration of inspired oxygen; TLC, total leukocyte Count; AIDS, acquired immunodeficiency syndrome; PAR, pressure adjusted heart rate (HR × (central venous pressure/MAP)); PT, prothrombin time; AVPU, alert-voice-pain-unresponsive; WBC, white blood cell Counts; LOS, length of stay; ICUA, intensive care unit Admission; HF, heart failure; NYHA, new york heart association; MiV, minute ventilation; CPAP, continuous positive pressure ventilation; AST/ALT, Aspartate aminotranferase/Alanine aminotransferase
Studies on fetal outcomes and their predictors in obstetric ICU patients
|
|
|
|
|---|---|---|
| Cartin-Ceba et al.[ | Fetal deaths—32 Neonatal deaths—10 | Fetal loss—maternal shock (OR 6.85); maternal transfusion of blood products (OR 7.24); lower gestational age (OR 1.2/week <37 weeks). |
| Pollock et al.[ | Median mortality rate 20% (IQR 11–32%) | — |
| Aoyama et al.[ | — | Maternal shock; lower gestational age; severe maternal hypoxemia |
| Rios et al.[ | 23 fetal and neonatal deaths | |
| Devabaktuni et al.[ | 21.42% perinatal mortality rate for 42 patients. Live term 54.76%; IUD 7.14%; neonatal deaths 4.76% | |
| Saif et al.[ | Perinatal mortality rate 271/1000 live births [significantly higher among nonsurvivors, OR 8.2 (4.1–16.7), | |
| Vasquez et al.[ | 17% fetal-neonatal loss | |
| Lawton et al.[ | Perinatal mortality rate: 53.1/1000 live births 94.1% live births; 3.2% fetal deaths: 2% neonatal deaths, 2.7% early trimester loss | PIH (most common) Maternal cardiac condition Maternal sepsis |
| Miglani et al.[ | Low APGAR score requiring NICU admission (29.12%); IUD (12.6%); early neonatal death (7.76%); stillbirth (4.85%); perinatal morbidity (29.12%); perinatal mortality (31.06%) | All MFN outcomes significantly worse in referred patients, except perinatal morbidity. Higher APACHE II scores associated with perinatal mortality ( |
| Ozumba et al.[ | 47.2% perinatal mortality |
Level 1, 2, 3 delays: delay in seeking care, in reaching appropriate healthcare facility, and at tertiary care center, respectively. IQR, interquartile range; IUD, intrauterine death; NICU, neonatal intensive care unit; OR, odds ratio; MFN, maternofetal neonatal